The company will use the funds to accelerate the clinical development and commercialization of its minimal residual disease detection C2-Intelligence Platform.
Under their 10-year partnership, IBM will install an early instance of its Quantum System One at Cleveland Clinic to promote AI-driven life sciences discovery.
Under the five-year agreement, Amazon has made an undisclosed investment in KMPM and is supporting the firm's Lattice integrated diagnostic data platform.
Initial partners in the program include Thermo Fisher Scientific, GNS Healthcare, DNAnexus, Personal Genome Diagnostics, and the Wellcome Sanger Institute.
